titoli, abstracts, parole chiave >>>
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

Sester, Martina and Sotgiu, Giovanni and Lange, Christoph and Giehl, Claudia and Girardi, Enrico and Migliori, Giovanni Battista and Bossink, Aik and Dheda, Keertan and Diel, R. and Domínguez, J. and Lipman, M. and Nemeth, J. and Ravn, P. and Winkler, S. and Huitric, Emma and Sandgren, Andreas and Manissero, Davide (2011) Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. European Respiratory Journal, Vol. 37 (1), p. 100-111. eISSN 1399-3003. Article.

Full text not available from this repository.

Alternative URLs:


Interferon-γ release assays (IGRAs) are now established for the immunodiagnosis of latent infection with Mycobacterium tuberculosis in many countries. However, the role of IGRAs for the diagnosis of active tuberculosis (TB) remains unclear.
Following preferred reporting items for systematic reviews and meta-analyses (PRISMA) and quality assessment of diagnostic accuracy studies (QUADAS) guidelines, we searched PubMed, EMBASE and Cochrane databases to identify studies published in January 2001–November 2009 that evaluated the evidence of using QuantiFERON-TB® Gold in-tube (QFT-G-IT) and T-SPOT.TB® directly on blood or extrasanguinous specimens for the diagnosis of active TB.
The literature search yielded 844 studies and 27 met the inclusion criteria. In blood and extrasanguinous fluids, the pooled sensitivity for the diagnosis of active TB was 80% (95% CI 75–84%) and 48% (95% CI 39–58%) for QFT-G-IT, and 81% (95% CI 78–84%) and 88% (confirmed and unconfirmed cases) (95% CI 82–92%) for T-SPOT.TB®, respectively. In blood and extrasanguinous fluids, the pooled specificity was 79% (95% CI 75–82%) and 82% (95% CI 70–91%) for QFT-G-IT, and 59% (95% CI 56–62%) and 82% (95% CI 78–86%) for T-SPOT.TB®, respectively.
Although the diagnostic sensitivities of both IGRAs were higher than that of tuberculin skin tests, it was still not high enough to use as a rule out test for TB. Positive evidence for the use of IGRAs in compartments other than blood will require more independent and carefully designed prospective studies.

Item Type:Article
ID Code:6625
Uncontrolled Keywords:Interferon-γ release assays (IGRAs), Mycobacterium tuberculosis, Active Tuberculosis (TB)
Subjects:Area 06 - Scienze mediche > MED/01 Statistica medica
Divisions:001 Università di Sassari > 01 Dipartimenti > Scienze biomediche
Publisher:European Respiratory Society
Deposited On:22 Nov 2011 13:00

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page